JAK3-IN-14 is a potent, selective, and orally bioavailable small molecule inhibitor of FLT3, demonstrating nanomolar IC50 values against FLT3-WT, FLT3-D835Y, and FLT3-D835H mutants. It is a valuable research tool for investigating FLT3-driven pathologies, such as acute myeloid leukemia (AML), in both cellular and animal models.
Molecular Weight:
287.32
Purity:
98.98% (May vary between batches)
CAS Number:
[454234-24-3]
Formula:
C18H13N3O
Target:
JAK,FLT
Application Notes:
Solubility: DMSO:50 mg/mL (174.02 mM)
* VAT and and shipping costs not included. Errors and price changes excepted